Targeting Epithelial-Mesenchymal Transition Phenotype for Gastro-Intestinal Cancer

E-ISSN： 1873-4286|21|21|2942-2955

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.21, 2015-06, pp. : 2942-2955

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Pathways Contributing to Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian Cancer

Current Drug Targets, Vol. 13, Iss. 13, 2012-12 ,pp. : 1649-1653

Bentham Science Publishers

Access to resources Recommend Favorite

Epithelial-Mesenchymal Transition: Implications in Cancer Progression and Metastasis

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1881-1890

Bentham Science Publishers

Access to resources Recommend Favorite

The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer

Current Drug Targets, Vol. 11, Iss. 4, 2010-01 ,pp. : 474-481

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Cancer Vaccines Targeting Brachyury, a Transcription Factor Associated with Tumor Epithelial-Mesenchymal Transition

Cells Tissues Organs, Vol. 203, Iss. 2, 2017-02 ,pp. : 128-138

Karger

Access to resources Recommend Favorite

Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition

Cells Tissues Organs, Vol. 203, Iss. 2, 2017-02 ,pp. : 114-127

Karger

Access to resources Recommend Favorite